Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Müller

Showing results (211-220 of 301) with videos related to

Pageof 31
Sort By:
Annals of the Rheumatic Diseases|May 31, 2011
Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue diseaseJörg H W Distler, Tobias Strapatsas, Dörte Huscher, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 26, 2023
Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society GuidelinesOliver Distler, Diana Bonderman, J Gerry Coghlan, et al.
Arthritis Research & Therapy|November 20, 2016
Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilageAdam P Croft, Amy J Naylor, Jennifer L Marshall, et al.
Journal of Clinical Medicine|December 23, 2022
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)Michaela Koehm, Ann C Foldenauer, Tanja Rossmanith, et al.
Arthritis and Rheumatism|March 8, 2005
Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosisJörg H W Distler, Astrid Jüngel, Otylia Kowal-Bielecka, et al.
Molecular Pharmacology|January 27, 2004
Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-kappaB and simian virus 40 promoter factor 1 pathwaysJörg H W Distler, Claudia Hagen, Astrid Hirth, et al.
Rheumatology (Oxford, England)|March 19, 2021
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)Frank Behrens, Michaela Koehm, Tanja Rossmanith, et al.
Rheumatology (Oxford, England)|August 16, 2014
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standardsDinesh Khanna, Daniel E Furst, Yannick Allanore, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyJ Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
Vaccines|February 26, 2026
Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported StudyKarolina Gente, Benedikt Ditz, Eike Bormann, et al.
Pageof 31

Showing results (211-220 of 301) with videos related to

Sort By:
Pageof 31
Annals of the Rheumatic Diseases|May 31, 2011
Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue diseaseJörg H W Distler, Tobias Strapatsas, Dörte Huscher, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 26, 2023
Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society GuidelinesOliver Distler, Diana Bonderman, J Gerry Coghlan, et al.
Arthritis Research & Therapy|November 20, 2016
Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilageAdam P Croft, Amy J Naylor, Jennifer L Marshall, et al.
Journal of Clinical Medicine|December 23, 2022
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)Michaela Koehm, Ann C Foldenauer, Tanja Rossmanith, et al.
Arthritis and Rheumatism|March 8, 2005
Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosisJörg H W Distler, Astrid Jüngel, Otylia Kowal-Bielecka, et al.
Molecular Pharmacology|January 27, 2004
Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-kappaB and simian virus 40 promoter factor 1 pathwaysJörg H W Distler, Claudia Hagen, Astrid Hirth, et al.
Rheumatology (Oxford, England)|March 19, 2021
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)Frank Behrens, Michaela Koehm, Tanja Rossmanith, et al.
Rheumatology (Oxford, England)|August 16, 2014
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standardsDinesh Khanna, Daniel E Furst, Yannick Allanore, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyJ Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
Vaccines|February 26, 2026
Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported StudyKarolina Gente, Benedikt Ditz, Eike Bormann, et al.
Pageof 31